Invivyd (IVVD) Retained Earnings (2021 - 2025)
Invivyd posted quarterly Retained Earnings of -$954.5 million for Q4 2025, down 5.82% year-on-year from -$1.0 billion in Q4 2024, and down 1.17% on a QoQ basis from -$943.4 million in Q3 2025.
Invivyd (IVVD) has 5 years of Retained Earnings data on file, last reported at -$954.5 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 5.82% year-over-year to -$954.5 million; the trailing twelve-month figure through Dec 2025 stood at -$954.5 million (down 5.82% YoY), and the FY2025 full-year result was -$954.5 million, down 5.82% from the prior year.
- Retained Earnings for Q4 2025 stood at -$954.5 million, down from -$943.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $3000.0 in Q3 2021 and bottomed at -$954.5 million in Q4 2025.
- The 5-year median for Retained Earnings is -$296.2 million (2021), against an average of -$371.8 million.
- The widest annual swing landed in 2023, when Retained Earnings jumped 100.0%; it then sank 44179900.0% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$8000.0 in 2021, then plunged by 6667725.0% to -$533.4 million in 2022, then jumped by 100.0% to -$13000.0 in 2023, then slumped by 6938315.38% to -$902.0 million in 2024, then retreated by 5.82% to -$954.5 million in 2025.
- The last three Retained Earnings figures came in at -$954.5 million (Q4 2025), -$943.4 million (Q3 2025), and -$39000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | -954.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -954.48 Mn |
| Sep 30, 2025 | -943.41 Mn |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Dec 31, 2024 | -901.99 Mn |
| Sep 30, 2024 | -883.60 Mn |
| Jun 30, 2024 | -12,000.00 |
| Mar 31, 2024 | -775.57 Mn |
| Dec 31, 2023 | -13,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -618.98 Mn |
| Mar 31, 2023 | -115,000.00 |
| Dec 31, 2022 | -533.43 Mn |
| Sep 30, 2022 | -488.85 Mn |
| Jun 30, 2022 | -443.77 Mn |
| Dec 31, 2021 | -8,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | -148.70 Mn |